Connect your AI

Avanos Medical AVNS Total Liabilities

Total Liabilities at other companies

StrykerSYK

$23.31B-7.0%

Pacira BioSciences, Inc.PCRX

$554.64M-29.6%

MedtronicMDT

$42.96B-1.1%

Collegium Pharmaceutical, Inc.COLL

$1.34B-4.1%

IAR

Integra LifeSciencesIART

$2.54B+0.3%

Boston ScientificBSX

——

Other financials

Income statement

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Avanos Medical's total liabilities?: Avanos Medical (AVNS) reported total liabilities of $268M in Q1 2026.
How has Avanos Medical's total liabilities changed year-over-year?: Avanos Medical's total liabilities decreased by 0.1% year-over-year, from $268.4M to $268M.
What is the long-term trend for Avanos Medical's total liabilities?: Over 5 years (2020 to 2025), Avanos Medical's total liabilities has grown at a -6.6% compound annual growth rate (CAGR), from $416.3M to $295.5M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.